CRMEX
Price
$7.59
Change
-$0.06 (-0.78%)
Updated
Sep 20 closing price
VMCPX
Price
$352.79
Change
-$0.65 (-0.18%)
Updated
Sep 20 closing price
Ad is loading...

CRMEX vs VMCPX

Header iconCRMEX vs VMCPX Comparison
Open Charts CRMEX vs VMCPXBanner chart's image
CRM All Cap Value I
Price$7.59
Change-$0.06 (-0.78%)
VolumeN/A
CapitalizationN/A
Vanguard Mid Cap Index InstitutionalPlus
Price$352.79
Change-$0.65 (-0.18%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
CRMEX vs VMCPX Comparison Chart
Loading...
VS
CRMEX vs. VMCPX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRMEX is a Buy and VMCPX is a Buy.

FUNDAMENTALS
Fundamentals
VMCPX has more cash in the bank: 172B vs. CRMEX (25.1M). VMCPX pays higher dividends than CRMEX: VMCPX (1.51) vs CRMEX (0.11). CRMEX was incepted earlier than VMCPX: CRMEX (18 years) vs VMCPX (14 years). CRMEX is a more actively managed with annual turnover of: 51.00 vs. VMCPX (13.00). CRMEX has a lower initial minimum investment than VMCPX: CRMEX (2500) vs VMCPX (100000000). VMCPX (25.17) and CRMEX (23.97) have marching annual gain over last year. VMCPX return over 5 years is better than : 56.93 vs. CRMEX (10.42).
CRMEXVMCPXCRMEX / VMCPX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence18 years14 years-
Gain YTD15.52512.593123%
Front LoadN/AN/A-
Min. Initial Investment25001000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets25.1M172B0%
Annual Yield % from dividends0.111.517%
Returns for 1 year23.9725.1795%
Returns for 3 years-9.379.85-95%
Returns for 5 years10.4256.9318%
Returns for 10 years-38.85128.75-30%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACHR3.060.01
+0.33%
Archer Aviation
SBT4.64-0.02
-0.43%
Sterling Bancorp
EBAY62.75-0.47
-0.74%
eBay
CNXC63.38-0.79
-1.23%
Concentrix Corp
NRBO3.19-0.07
-2.15%
NeuroBo Pharmaceuticals